Spinal MCP-1 Contributes to Central Post-stroke Pain by Inducing Central Sensitization in Rats

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2023 Jan 5

PMID 36602702

Authors

Fei Yang

Jun-Jie Jing

Si-Yin Fu

Xiu-Zhu Su

Yu-Ling Zhong

Dong-Sheng Chen

Xiao-Zhi Wu

Yi-Qing Zou

Affiliations

Soon will be listed here.

Abstract

Central post-stroke pain (CPSP) is a highly refractory form of central neuropathic pain that has been poorly studied mechanistically. Recent observations have emphasized the critical role of the spinal dorsal horn in CPSP. However, the underlying mechanisms remain unclear. In this study, rats were subjected to thalamic hemorrhage to investigate the role of spinal monocyte chemoattractant protein-1 (MCP-1) and C-C motif chemokine receptor 2 (CCR2) in the development of CPSP. Immunohistochemical staining and ELISA were used to assess the expression changes of c-Fos, Iba-1, GFAP, MCP-1, and CCR2 in the dorsal horn of the lumbar spinal cord following thalamic hemorrhage, and the involvement of spinal MCP-1 in CPSP was examined by performing intrathecal anti-MCP-1 mAb injection to neutralize the spinal extracellular MCP-1. We demonstrated that intra-thalamic collagenase microinjection induced persistent bilateral mechanical pain hypersensitivity and facilitated the spontaneous pain behaviors evoked by intraplantar bee venom injection. Accompanying CPSP, the expression of c-Fos, Iba-1, and GFAP in the lumbar spinal dorsal horn was significantly increased up to 28 days post-intra-thalamic collagenase microinjection. Intrathecal injection of minocycline and fluorocitrate dramatically reverses the bilateral mechanical pain hypersensitivity. Moreover, intra-thalamic collagenase microinjection dramatically induced the up-regulation of MCP-1 but had no effect on the expression of CCR2 in the bilateral lumbar spinal dorsal horn, and MCP-1 was primarily localized in the neuron. Intrathecal injection of anti-MCP-1 mAb was also able to reverse CPSP and reduce the expression of c-Fos, Iba-1, and GFAP in the lumbar spinal dorsal horn. These findings indicated that spinal MCP-1 contributes to CPSP by mediating the activation of spinal neurons and glial cells following thalamic hemorrhage stroke, which may provide insights into pharmacologic treatment for CPSP.

Citing Articles

Progress of research into microglial mediation of central post-stroke pain.

Li Y, Dang Z, Li S, Li G, Cai H, Lu Y Int J Immunopathol Pharmacol. 2024; 38:3946320241309220.

PMID: 39699048 PMC: 11660280. DOI: 10.1177/03946320241309220.

The P2X7 Hypothesis of Central Post-Stroke Pain.

Huang A, Shih H, Shyu B Int J Mol Sci. 2024; 25(12).

PMID: 38928280 PMC: 11204365. DOI: 10.3390/ijms25126577.

CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings.

Ciechanowska A, Mika J Int J Mol Sci. 2024; 25(7).

PMID: 38612597 PMC: 11011591. DOI: 10.3390/ijms25073788.

An Overview of the Mechanisms Involved in Neuralgia.

Zhang B, Dong H, Wu Z, Jiang X, Zou W J Inflamm Res. 2023; 16:4087-4101.

PMID: 37745793 PMC: 10516189. DOI: 10.2147/JIR.S425966.

Targeting Members of the Chemokine Family as a Novel Approach to Treating Neuropathic Pain.

Pawlik K, Mika J Molecules. 2023; 28(15).

PMID: 37570736 PMC: 10421203. DOI: 10.3390/molecules28155766.

References

Urits I, Gress K, Charipova K, Orhurhu V, Freeman J, Kaye R . Diagnosis, Treatment, and Management of Dejerine-Roussy Syndrome: a Comprehensive Review. Curr Pain Headache Rep. 2020; 24(9):48. DOI: 10.1007/s11916-020-00887-3. View

Sahin-Onat S, Unsal-Delialioglu S, Kulakli F, Ozel S . The effects of central post-stroke pain on quality of life and depression in patients with stroke. J Phys Ther Sci. 2016; 28(1):96-101. PMC: 4755983. DOI: 10.1589/jpts.28.96. View

Paolucci S, Iosa M, Toni D, Barbanti P, Bovi P, Cavallini A . Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study. Pain Med. 2016; 17(5):924-30. DOI: 10.1093/pm/pnv019. View

Hosomi K, Seymour B, Saitoh Y . Modulating the pain network--neurostimulation for central poststroke pain. Nat Rev Neurol. 2015; 11(5):290-9. DOI: 10.1038/nrneurol.2015.58. View

Choi H, Aktas A, Bottros M . Pharmacotherapy to Manage Central Post-Stroke Pain. CNS Drugs. 2021; 35(2):151-160. DOI: 10.1007/s40263-021-00791-3. View

Plecash A, Chebini A, Ip A, Lai J, Mattar A, Randhawa J . Updates in the Treatment of Post-Stroke Pain. Curr Neurol Neurosci Rep. 2019; 19(11):86. DOI: 10.1007/s11910-019-1003-2. View

Shih H, Kuan Y, Shyu B . Targeting brain-derived neurotrophic factor in the medial thalamus for the treatment of central poststroke pain in a rodent model. Pain. 2017; 158(7):1302-1313. PMC: 5472007. DOI: 10.1097/j.pain.0000000000000915. View

Liu T, Li T, Chen X, Li Z, Feng M, Yao W . EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. J Neuroinflammation. 2021; 18(1):211. PMC: 8447610. DOI: 10.1186/s12974-021-02255-3. View

Lu J, Guo X, Yan M, Yuan X, Chen S, Wang Y . P2X4R Contributes to Central Disinhibition Via TNF-α/TNFR1/GABAaR Pathway in Post-stroke Pain Rats. J Pain. 2021; 22(8):968-980. DOI: 10.1016/j.jpain.2021.02.013. View

10.

Fu G, Du S, Huang T, Cao M, Feng X, Wu S . FTO (Fat-Mass and Obesity-Associated Protein) Participates in Hemorrhage-Induced Thalamic Pain by Stabilizing Toll-Like Receptor 4 Expression in Thalamic Neurons. Stroke. 2021; 52(7):2393-2403. PMC: 8423095. DOI: 10.1161/STROKEAHA.121.034173. View

11.

An J, Shi W, Zhang J, Qian X, Fang Q, Wang Y . A New Rat Model of Thalamic Pain Produced by Administration of Cobra Venom to the Unilateral Ventral Posterolateral Nucleus. Pain Physician. 2019; 22(6):E635-E647. View

12.

Harada S, Matsuura W, Takano M, Tokuyama S . Proteomic Profiling in the Spinal Cord and Sciatic Nerve in a Global Cerebral Ischemia-Induced Mechanical Allodynia Mouse Model. Biol Pharm Bull. 2016; 39(2):230-8. DOI: 10.1248/bpb.b15-00647. View

13.

Matsuura W, Harada S, Liu K, Nishibori M, Tokuyama S . Evidence of a role for spinal HMGB1 in ischemic stress-induced mechanical allodynia in mice. Brain Res. 2018; 1687:1-10. DOI: 10.1016/j.brainres.2018.02.026. View

14.

Matsuura W, Nakamoto K, Tokuyama S . The Involvement of DDAH1 in the Activation of Spinal NOS Signaling in Early Stage of Mechanical Allodynia Induced by Exposure to Ischemic Stress in Mice. Biol Pharm Bull. 2019; 42(9):1569-1574. DOI: 10.1248/bpb.b19-00371. View

15.

Yang F, Fu H, Lu Y, Wang X, Yang Y, Yang F . Post-stroke pain hypersensitivity induced by experimental thalamic hemorrhage in rats is region-specific and demonstrates limited efficacy of gabapentin. Neurosci Bull. 2014; 30(6):887-902. PMC: 4357321. DOI: 10.1007/s12264-014-1477-5. View

16.

Yang F, Luo W, Sun W, Wang Y, Wang J, Yang F . SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal Interactions. Front Mol Neurosci. 2017; 10:226. PMC: 5519565. DOI: 10.3389/fnmol.2017.00226. View

17.

Wasserman J, Koeberle P . Development and characterization of a hemorrhagic rat model of central post-stroke pain. Neuroscience. 2009; 161(1):173-83. DOI: 10.1016/j.neuroscience.2009.03.042. View

18.

Castel A, Helie P, Beaudry F, Vachon P . Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine. BMC Vet Res. 2013; 9:59. PMC: 3618296. DOI: 10.1186/1746-6148-9-59. View

19.

De Vloo P, Morlion B, van Loon J, Nuttin B . Animal models for central poststroke pain: a critical comprehensive review. Pain. 2016; 158(1):17-29. DOI: 10.1097/j.pain.0000000000000722. View

20.

Yang Y, Yang F, Yang F, Li C, Wang Y, Li Z . Gabapentinoid Insensitivity after Repeated Administration is Associated with Down-Regulation of the α(2)δ-1 Subunit in Rats with Central Post-Stroke Pain Hypersensitivity. Neurosci Bull. 2016; 32(1):41-50. PMC: 5563753. DOI: 10.1007/s12264-015-0008-3. View